Published in J Immunol on January 15, 1999
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med (2000) 2.09
Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi. Infect Immun (2000) 1.46
Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother (2001) 1.39
Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun (2005) 1.18
Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo. Infect Immun (2007) 1.13
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun (2005) 1.09
Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun (2002) 0.97
Ebola: translational science considerations. J Transl Med (2015) 0.96
Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation (2009) 0.94
Vaccine Development Against Leishmania donovani. Front Immunol (2012) 0.90
Inducible nitric oxide synthase deficiency in mice increases resistance to chronic infection with Echinococcus multilocularis. Immunology (2003) 0.87
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice. PLoS One (2011) 0.87
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection. PLoS Negl Trop Dis (2012) 0.84
Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun (2005) 0.80
Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections. Infect Immun (2002) 0.77
Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation. Iran J Parasitol (2012) 0.76
The breast tumor microenvironment alters the phenotype and function of natural killer cells. Cell Mol Immunol (2015) 0.76
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis. Parasit Vectors (2015) 0.75
Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis. Antimicrob Agents Chemother (2008) 0.75
Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Health (2016) 0.75
Concepts of immunostimulation to increase antiparasitic drug action. Parasitol Res (2003) 0.75
Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol (2001) 2.70
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol (1999) 2.53
Sequence-dependent DNA structure: tetranucleotide conformational maps. J Mol Biol (2000) 2.13
Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett (2008) 2.04
IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol (2001) 1.99
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93
Sequence-dependent DNA structure: dinucleotide conformational maps. J Mol Biol (2000) 1.86
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83
Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology (1995) 1.76
T-cell responses and immunity to experimental infection with leishmania major. Annu Rev Immunol (1989) 1.68
Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun (1994) 1.66
Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun (2002) 1.65
Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc Natl Acad Sci U S A (1995) 1.59
An Epidemic of Diarrhea in a New-Born Nursery Caused by Pseudomonas aeruginosa. Am J Public Health Nations Health (1947) 1.51
Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A (1998) 1.50
gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48
IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol (1999) 1.45
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun (1997) 1.44
Experimental cutaneous leishmaniasis. I. Nonspecific immunodepression in BALB/c mice infected with Leishmania tropica. J Immunol (1981) 1.40
IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol (1998) 1.38
Leishmaniasis in beige mice. Infect Immun (1982) 1.36
Structure and conformation of helical nucleic acids: analysis program (SCHNAaP). J Mol Biol (1997) 1.36
The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun (2000) 1.31
Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J Infect Dis (2002) 1.24
The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol (1999) 1.22
Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg (1982) 1.22
Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol (1987) 1.21
Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics (1981) 1.21
Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun (2000) 1.21
IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol (1999) 1.20
A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc Natl Acad Sci U S A (1998) 1.18
Acute low back pain. Comparison of two conservative treatment approaches. Med J Aust (1982) 1.14
The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology. J Immunol (1999) 1.14
Sequence-dependent DNA structure: the role of the sugar-phosphate backbone. J Mol Biol (1998) 1.14
Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect Immun (1995) 1.13
The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol (1995) 1.13
Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol (2000) 1.13
Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol (2008) 1.12
Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol (2000) 1.07
Structure and conformation of helical nucleic acids: rebuilding program (SCHNArP). J Mol Biol (1997) 1.06
Immunoregulation during toxoplasmosis. Chem Immunol (1998) 1.06
Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell Immunol (1985) 1.04
Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun (1994) 1.02
Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. J Immunol (1999) 1.01
Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol (1994) 1.01
Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters. Infect Immun (1989) 1.00
Negative regulation of Th17 responses. Semin Immunol (2008) 0.99
Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol (1994) 0.99
Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest (1995) 0.99
Feline giardiasis: observations on natural and induced infections. Am J Vet Res (1984) 0.98
Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production. Infect Immun (1997) 0.97
Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Ther (2001) 0.97
Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology (1987) 0.97
Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem Parasitol (1998) 0.97
Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of the T cell response before treatment. J Infect Dis (1996) 0.96
Experimental cutaneous leishmaniasis: induction and regulation of T cells following infection of mice with Leishmania major. Chem Immunol (1998) 0.96
Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect Immun (2000) 0.94
Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses. Infect Immun (1994) 0.92
A role for CD44 in the production of IFN-gamma and immunopathology during infection with Toxoplasma gondii. J Immunol (2001) 0.92
Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol (2004) 0.91
Quantitative measurements of edge-to-face aromatic interactions by using chemical double-mutant cycles. Chemistry (2001) 0.91
The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation. J Immunol (2001) 0.90
Quantitative determination of intermolecular interactions with fluorinated aromatic rings. Chemistry (2001) 0.89
Splenic natural killer-cell activity in mice infected with Leishmania donovani. Cell Immunol (1984) 0.89
IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Parasite Immunol (2004) 0.88
A supramolecular system for quantifying aromatic stacking interactions. Chemistry (2001) 0.87
Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol (2001) 0.86
Sensory neuroanatomy of a passively ingested nematode parasite, Haemonchus contortus: amphidial neurons of the first stage larva. J Comp Neurol (2000) 0.85
Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster. Exp Parasitol (1976) 0.84
Proliferative glomerulonephritis in experimental Leishmania donovani infection of the golden hamster. Comp Immunol Microbiol Infect Dis (1981) 0.84
Sensory neuroanatomy of a passively ingested nematode parasite, Haemonchus contortus: amphidial neurons of the third-stage larva. J Parasitol (2001) 0.83
Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Trans R Soc Trop Med Hyg (1993) 0.83
Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol (2001) 0.83
Patients infected with Leishmania donovani chagasi can have antibodies that recognize heat shock and acidic ribosomal proteins of Trypanosoma cruzi. Mol Biochem Parasitol (1991) 0.82
Inhibition of in vivo and in vitro infectivity of Leishmania donovani by tunicamycin. Mol Biochem Parasitol (1985) 0.82
Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone. Exp Parasitol (1997) 0.82
Protective immune responses of the jird to larval Dipetalonema viteae. Immunology (1986) 0.81
The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathol Appl Neurobiol (1997) 0.81
Alkylamine sensing using langmuir-blodgett films of n-alkyl-N-phenylamide-substituted zinc porphyrins. J Phys Chem B (2008) 0.79
Experimental infections of the multimammate rat (Mastomys natalensis) with Leishmania donovani and Leishmania major. Am J Trop Med Hyg (1987) 0.79
Detection of volatile organic compounds using porphyrin derivatives. J Phys Chem B (2010) 0.79
Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody. Am J Trop Med Hyg (1995) 0.79
In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infect Immun (1996) 0.79
Presence of delta-sleep-inducing peptide-like material in human milk. J Clin Endocrinol Metab (1984) 0.79
Pathogenesis of anaemia in hamsters infected with Leishmania donovani. Z Parasitenkd (1982) 0.79
Sequence-structure relationships in DNA oligomers: a computational approach. J Am Chem Soc (2001) 0.78
Cellular and humoral immune responses of jirds resistant to Dipetalonema viteae infection. Infect Immun (1986) 0.78
Subsets of specific T cells and experimental cutaneous leishmaniasis. Ann Inst Pasteur Immunol (1988) 0.78
Mechanisms of depression of splenic natural killer cell function in C57BL/6 mice infected with Leishmania donovani. Cell Immunol (1984) 0.78
Altered endochondral ossification in collagen X mouse models leads to impaired immune responses. Dev Dyn (2008) 0.78
Immunity to Toxoplasma gondii--into the 21st century. Parasite Immunol (2015) 0.77
Similarity in variable antigen type composition of Trypanosoma brucei rhodesiense populations in different sites within the mouse host. Trans R Soc Trop Med Hyg (1986) 0.77
Self-assembly of oligomeric porphyrin rings. Org Lett (2000) 0.77
Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis. Antimicrob Agents Chemother (1997) 0.76
Passive stretch relationships in human uterine muscle. Am J Obstet Gynecol (1966) 0.76
Leishmania chagasi and L. donovani: experimental infections in domestic cats. Exp Parasitol (1984) 0.76